Project: nciOncology
Class Angiogenesis_Activator_Inhibitor

Concrete Class Extends 

        Angiogenesis_Inhibitor

 

Direct Instances:

None

 

Direct Subclasses:

1. SU6668
2. Penicillamine
3. NM-3
4. Interferon_Alfa_Therapeutic_
5. Neovastat
6. PTK787_ZK_222584
7. Aplidine
8. Leflunomide
9. Bevacizumab
10. Nafoxidine
11. Tamoxifen
12. Suradista
13. VEGF_Trap
14. Pentosan_Polysulfate
15. Clomiphene
16. DAB389_Epidermal_Growth_Factor
17. Roquinimex
18. HuMV833
19. Tecogalan_Sodium
20. Semaxanib
21. GEM_220
22. IM-862
23. ZD-6474

Template Slots
Slot name	Documentation	Type	Allowed Values/Classes	Cardinality	Default
rChemical_or_Drug_Has_Biochemical_Class_or_Structure		Instance	Chemicals_and_Drugs_Kind	0:*
rChemical_or_Drug_Has_Target_Protein		Instance	Protein_Kind	0:*
rChemical_or_Drug_Has_Target_Anatomy		Instance	Anatomy_Kind	0:*
rChemical_or_Drug_Affects_Cell_Type_or_Tissue		Instance	Anatomy_Kind	0:*
rChemical_or_Drug_Has_Source		Instance	Organism_Kind	0:*
rChemical_or_Drug_Has_Target_Organism		Instance	Organism_Kind	0:*
rChemical_or_Drug_Plays_Role_in_Biological_Process		Instance	Biological_Process_Kind	0:*
rChemical_or_Drug_Has_Biochemical_Function		Instance	Protein_Kind	0:*
rChemical_or_Drug_Has_Receptor		Instance	Protein_Kind	0:*
rChemical_or_Drug_Has_Associated_Pathology		Instance	Findings_and_Disorders_Kind	0:*
rChemical_or_Drug_FDA_Approved_for_Disease		Instance	Findings_and_Disorders_Kind	0:*
rChemical_or_Drug_is_Part_of_Chemical_or_Drug		Instance	Chemicals_and_Drugs_Kind	0:*

Own Slots
Slot name	Documentation	Type	Value	Cardinality
:OWL-DISJOINT-CLASSES		Instance

Return to class hierarchy